| scholarly article | Q13442814 |
| P2093 | author name string | Vasanthapuram Ravi | |
| Shampur Narayan Madhusudana | |||
| Kader Muhamuda | |||
| P433 | issue | 5 | |
| P921 | main subject | rabies | Q39222 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 192-195 | |
| P577 | publication date | 2007-05-03 | |
| P1433 | published in | Hum Vaccin | Q15755183 |
| P1476 | title | Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies. | |
| P478 | volume | 3 |
| Q33514828 | Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans |
| Q33816066 | Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. |
| Q37548799 | Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer |
| Q37530343 | Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies |
| Q56741242 | Four Thousand Years of Concepts Relating to Rabies in Animals and Humans, Its Prevention and Its Cure |
| Q38006132 | Passive immunity in the prevention of rabies. |
| Q45357009 | Preparation and identification of anti-rabies virus monoclonal antibodies |
| Q36788708 | Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. |
| Q39547355 | Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults |
Search more.